Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 1;44(5):357-360.
doi: 10.14503/THIJ-16-5879. eCollection 2017 Oct.

Tolerance of Sustained Ventricular Fibrillation During Continuous-Flow Left Ventricular Assist Device Support

Andrew C W Baldwin, Courtney J Gemmato, Elena Sandoval, William E Cohn, Jeffrey A Morgan, O H Frazier

Tolerance of Sustained Ventricular Fibrillation During Continuous-Flow Left Ventricular Assist Device Support

Andrew C W Baldwin et al. Tex Heart Inst J. .

Abstract

The widespread use of continuous-flow left ventricular assist devices for mechanical circulatory support has shown that long-term hemodynamic support is possible, even when a clinical "pulse" cannot be detected. We present the incidental discovery of ventricular fibrillation in 6 alert, hemodynamically stable patients supported only by a continuous-flow device (HeartMate II, n=5; Jarvik 2000, n=1). Ventricular fibrillation was found in 3 patients during routine outpatient follow-up visits and in 3 awaiting discharge from the hospital after device placement. Diagnosis was confirmed by electrocardiographic and echocardiographic studies. The average duration of mechanical circulatory support before ventricular fibrillation occurred was 221 ± 362 days (range, 5-864 d). All patients were conscious and ambulatory at the time of the arrhythmia. Three patients reported symptoms-primarily fatigue, nausea, and exertional dyspnea-that prompted evaluation. Serum chemistry analysis of blood drawn immediately after diagnosis showed no changes that suggested end-organ dysfunction. Three patients died of unrelated complications an average of 3.9 yr (range, 360-2,270 d) after the event. Two of the remaining 3 patients eventually underwent successful pump explantation, and one is on ongoing support. Our experience shows that it is possible for patients with continuous-flow left ventricular assist devices to remain hemodynamically stable while in ventricular fibrillation. Additional investigation is needed to determine whether defibrillator settings for these patients should be adjusted to limit delivery of shock therapy.

Keywords: Arrhythmias, cardiac; assisted circulation/instrumentation/methods; disease-free survival; heart failure/therapy; heart-assist devices; recovery of function; survival rate; time factors; ventricular fibrillation/physiopathology.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Transesophageal echocardiogram confirms ventricular fibrillation in a patient supported entirely by a continuous-flow left ventricular assist device.
See this image and copyright information in PMC

References

    1. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S.. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007; 99 8: 1151– 3. - PubMed
    1. Fasseas P, Kutalek SP, Kantharia BK.. Prolonged sustained ventricular fibrillation without loss of consciousness in patients supported by a left ventricular assist device. Cardiology 2002; 97 4: 210– 3. - PubMed
    1. Salzberg SP, Lachat ML, Zund G, Turina MI.. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. Eur J Cardiothorac Surg 2004; 26 2: 444– 6. - PubMed
    1. Gibbon JH., Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 37 3: 171– 85; passim. - PubMed
    1. Saxton GA Jr, Andrews CB.. An ideal heart pump with hydrodynamic characteristics analogous to the mammalian heart. Trans Am Soc Artif Intern Organs 1960; 6: 288– 91. - PubMed